BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6448464)

  • 21. [3 cases of lichen induced by pyritinol].
    Duterque M; Crouzet J; Civatte J
    Ann Dermatol Venereol; 1983; 110(9):707-8. PubMed ID: 6660771
    [No Abstract]   [Full Text] [Related]  

  • 22. [Myasthenia induced successively by pyritinol, then by captopril, in rheumatoid polyarthritis].
    Kirjner M; Koeger AC; Camus JP
    Therapie; 1987; 42(2):250. PubMed ID: 3303433
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nephrotic syndrome during a treatment of rheumatoid polyarthritis with pyritinol].
    Raul P; Pourel J; Wiederkehr P; Kessler M; Duheille J; Foliguet B; Grignon M
    Therapie; 1982; 37(4):492-3. PubMed ID: 7135333
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxic hepatitis induced by pyrithioxin during rheumatoid polyarthritis].
    Valat J; Gatti P; Sichere P; Metman E; Dorval ED
    Nouv Presse Med; 1982 May; 11(24):1875. PubMed ID: 7110937
    [No Abstract]   [Full Text] [Related]  

  • 25. [Extramembranous glomerulonephritis in rheumatoid polyarthritis. Possible role of pyrithioxin].
    Trèves R; Desproges-Gotteron R; Benevent D; Benevent J; Leroux-Robert C
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):309-10. PubMed ID: 6879101
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in various humoral immunity indicators during the treatment of rheumatoid arthritis with D-penicillamine (cuprenil)].
    Chwalińska-Sadowska H; Małdykowa H; Zajaczek-Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Swierczyńska Z; Orłowska G; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1981; 19(2):151-7. PubMed ID: 6459630
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinico-immunological and biochemical indicators in the evaluation of pathological process in patients with rheumatoid arthritis].
    Mikunis RI; Dubovoĭ AF; Kozlova TV
    Ter Arkh; 1985; 57(8):100-2. PubMed ID: 2933837
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pyrithioxin (Encephabol) in the treatment of patients with organic psychosyndrom in involution. Clinical, EEG and experimental psychological study (author's transl)].
    Misurec J; Sláma B; Náhunek K
    Cesk Psychiatr; 1976 Feb; 72(1):14-23. PubMed ID: 773551
    [No Abstract]   [Full Text] [Related]  

  • 29. [Auto-immune hypoglycemic syndrome induced by pyritinol].
    Faguer de Moustier B; Burgard M; Boitard C; Desplanque N; Fanjoux J; Tchobroutsky G
    Diabete Metab; 1988; 14(4):423-9. PubMed ID: 3066650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Our experience with pyritinol in patient with brain concussion].
    Bystrický Z; Zouhar A; Janík B
    Med Welt; 1977 Apr; 28(13):643-6. PubMed ID: 323638
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of massive-dose intravenous corticosteroids (pulse methylprednisolone) in rheumatoid arthritis. Clinical and immunological results].
    Duquesnoy B; Vannimenus PY; Thevenon A; Delcambre B
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):477-81. PubMed ID: 6334352
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of Biontabol].
    Dubrulie P; Degorre JP
    Lille Med; 1976 Sep; 21(7 Suppl 3):616-9. PubMed ID: 994693
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatitis induced by pyrithioxine: direct toxicity or idiosyncrasy?].
    Gouet D; Alcalay M; Briaud M; Touchard G; Bontoux D
    Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):167-8. PubMed ID: 6857132
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of cryoglobulinemia with pyritinol].
    Giovanelli E; Neretto G; Poccardi G; Sabbaa S; Poletti T
    Haematologica; 1982 Jun; 67(3):486-7. PubMed ID: 6815007
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical trial of Encephabol ampules in neurological and neurosurgical coma].
    Anghel M; Tetraru C; Popa G; Bazon S; Vasiliu V
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(1):137-9. PubMed ID: 397581
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pyritinol in the ambulatory geriatric patient. A placebo controled combined study].
    Gonçalves N
    Med Welt; 1979 Mar; 30(13):494-8. PubMed ID: 372727
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
    Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T
    J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo-controlled study of pyritinol ('Encephabol') in dementia.
    Cooper AJ; Magnus RV
    Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience with pyritinol-infusion by acute brain injury (author's transl)].
    Oh SY
    Schweiz Rundsch Med Prax; 1975 Jul; 64(26):840-2. PubMed ID: 1144303
    [No Abstract]   [Full Text] [Related]  

  • 40. Tamitinol in paedopsychiatric out-patient therapy.
    Sanz R; Bettschart W; Reinhardt B
    Pharmatherapeutica; 1981; 3(1):40-5. PubMed ID: 7323108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.